Solasia Pharma K.K. (TYO:4597)

Solasia Pharma K.K. Revenue

Solasia Pharma K.K. had revenue of 6.00M JPY in the quarter ending March 31, 2026, a decrease of -76.00%. This brings the company's revenue in the last twelve months to 410.00M, up 24.24% year-over-year. In the year 2025, Solasia Pharma K.K. had annual revenue of 429.00M with 35.76% growth.

• Revenue (ttm): 410.00M
• Revenue Growth: +24.24%
• P/S Ratio: 17.31
• Revenue / Employee: 18.64M
• Employees: 22
• Market Cap: 7.10B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	429.00M	113.00M	35.76%
Dec 31, 2024	316.00M	-301.00M	-48.78%
Dec 31, 2023	617.00M	-475.00M	-43.50%
Dec 31, 2022	1.09B	533.00M	95.35%
Dec 31, 2021	559.00M	105.00M	23.13%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 27, 2026

Data Sources Report a data error